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Abstract
Objective To determine the prevalence of solitary pulmonary
nodules (SPNs) in chest radiology studies and patient’s fea-
tures associated with malignancy in a non-high-risk clinical
population.
Methods Patients ≥35 years were referred for thoracic imaging
in two hospitals (2010-2011). Eight radiologists determined the
presence and characteristics of SPN. Selected variables were
collected from radiological register and medical records. Ob-
server agreement in the diagnosis of SPN was assessed.
Results 25,529 patients were included: 23,102 (90.5 %)
underwent chest radiograph and 2,497 (9.5 %) a CT. The
prevalence of SPNwas 2.1% (95% CI 1.9 – 2.3) in radiographs
and 17.0 % (95 % CI 15.5 – 18.5) in CT. In patients undergoing
chest radiograph, detection of SPN with an irregular border was
more frequent among smokers. In patients who had a CT, larger
SPNs appeared to be associated with 60 years of age or over,
diagnosis of a respiratory illness, or male gender. In addition, an
irregular border was also more common among men.
Conclusions The prevalence of SPNs detected by both radio-
graph and CTwas lower than that shown in screening studies.
Patient characteristics such as age, sex, respiratory disease, or
smoking habit were associated with nodule characteristics that
are known to be related with malignancy.
Key Points
• There is a lower SPN prevalence in the clinical population
than in screening studies.
• SPN prevalence is associated with some patient character-
istics: sex, age, imaging test.
• Nodule characteristics related to malignancy were associat-
ed with some patient characteristics.
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Introduction
Suspicion of lung cancer is a frequent event during the inter-
pretation of thoracic imaging tests, particularly since the use of
more sensitive tests like computed axial tomography (CT) has
become widespread [1]. When faced with a suspicious image,
radiologists must decide if it is necessary to carry out new
diagnostic procedures either on their own initiative or by
recommendation, or to recommend active surveillance when
the suspicion is minimal. This topic has been, and continues to
be, the object of a great deal of research [2, 3]. Physicians
evaluate the clinical probability of nodule malignancy either
through their experience or with the help of different quanti-
tative models, which are based on the scientific literature [4,
5]. The recommendations in the management of solitary pul-
monary nodules (SPN) were established by the American
College of Chest Physicians (ACCP) in 2007 [6], and have
been recently updated [5].
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Most of these predictive tools, based on patient and nodule
characteristics, come from high-risk populations undergoing
screening [7], which differ quite significantly from the unse-
lected population undergoing imaging in a routine setting (i.e.,
people with respiratory symptoms who seek medical care,
patients with other complaints, or asymptomatic patients with
incidental nodules). Screening trials use very strict inclusion
criteria [8, 9] such as the inclusion of individuals aged be-
tween 50 – 75 years with at least a 30 pack-year tobacco habit.
Applying the findings observed in these highly selected pop-
ulations to guide clinical decisions about nodules observed in
a routine clinical setting could, therefore, be flawed. The few
studies that are carried out in clinic-based populations have
limitations that hamper the application of their findings to a
wider setting (do not describe the selection process of the
patients included in the study [10–13], have small sample size
[14, 15], are retrospective [4], or include a very specific, and
thus, non-representative population [6]). Thus, there is cur-
rently insufficient evidence to develop useful quantitative
models for predicting malignancy following an SPN observed
in a routine clinic-based population.
In fact, the development of mathematical models to predict
malignancy in a clinic-based population requires knowledge is
some key aspects: the SPN prevalence in that setting, the
variation of SPN prevalence according to relevant variables,
the features of SPN in this population, and finally, the rela-
tionship between those SPN characteristics that have been
associated with malignancy (such as size or morphology of
the lesion) and some relevant variables. These data are rele-
vant to estimate the clinical ‘pretest’ probability of malignan-
cy of an SPN detected in a clinic-based population. Although
we have data about the prevalence of SPN in screening
populations [3], we are still not aware of the frequency of
SPN in a routine clinic-based setting. Moreover, according to
a previous systematic review [3], nodules detected in screen-
ing studies seem to be different from those detected in routine
clinical practice; a fact which further justifies the need to
investigate specifically this clinic-based population rather than
applying the results from screening studies.
Previous lung cancer screenings evaluated the utility of this
technique with or without sputum cytology [16]. However,
none of these previous studies evaluated the ability of chest
radiograph in the detection and characterization of the nod-
ules. The National Lung Screening Trial [7] compares the
efficacy of low-dose helical CT with chest radiograph. It
shows the different prevalences of SPN and the main variables
associated with them, according to the type of imaging test in
a high-risk population. Nevertheless, these data are lacking in
clinical practice. Although chest radiograph has a very low
sensitivity for the detection and characterization of SPNs in
comparison with CT, a significant number of SPNs are pri-
marily detected with chest radiograph in clinical practice.
Hence, it is essential to evaluate the different prevalence and
characteristics of SPN in clinical practice for both chest radio-
graph and CT.
The objective of this cross-sectional study was to determine
the prevalence and factors associated with SPNs, the relation-
ship between SPN characteristics related with malignancy and
relevant patient characteristics in chest radiology studies car-
ried out in the routine practice of radiology departments for
both chest radiograph and CT, and to compare these data with
the results shown in screening programs.
Methods
Patient population
A cross-sectional study of consecutive patients≥35 years re-
ferred for thoracic imaging evaluation in two hospitals in the
Valencian Community (Spain) were evaluated during the
years 2010 and 2011. San Juan Hospital (Alicante) and Dr.
Peset Hospital (Valencia) are two tertiary centres with a catch-
ment population of 234,424 and 377,780 people, respectively.
Although both hospitals are similar, only one of the centres
(Dr. Peset Hospital) included patients from the accident and
emergency department. All patients referred to the radiology
department from other hospital services and referrals from
primary health care centres were included.
All the patients with an imaging test (chest radiograph or
CT) during the period of study were included. When patients
underwent both tests only the first one was recorded. Those
patients who first had a chest radiograph and a CT later were
categorized as having had a chest radiograph. Thus, only those
patients who had a CT first were categorized as CT.
Chest radiographs were obtained with the standard tech-
nique in digital format (CR Philips at San Juan Hospital and
CR Agfa at Dr. Peset Hospital). The CT technique varied
according to the study that was being performed which in-
cluded non-contrast CT, contrast CT, CT angiography and
high-resolution CT. All chest CTs were obtained with a slice
thickness of 1.25 mm, 120 KvP, and variable mAs according
to the patient’s body weight.
Patients previously diagnosed with lung cancer and pa-
tients who were not residents of the Valencian Community
were excluded.
Institutional review board approval (University Miguel
Hernandez Committee Ref DSP-BLL-001-10) was obtained.
Given the fact that the study uses only routine data and no
additional interventions, informed consent was not sought
from the patients.
Data collection
Eight expert radiologists from both hospitals (four radiolo-
gists in each hospital) determined the presence of SPN in
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the thoracic study of all patients included. They used the
glossary for chest radiology, which defines SPN as an
opacity up to 30 mm in diameter, to describe SPN charac-
teristics [17, 18]. Thus, we limited our study to nodules
between 3 and 30 mm.
In all patients, selected variables were collected from the
radiological register: type of test performed (CT or radio-
graph); department that ordered the test; care setting (in-pa-
tient or out-patient); reason for test (respiratory, non-
respiratory, preoperative, neoplasm, or not specified); patient
characteristics (age, sex); and radiologist who performed the
test.
In patients with an SPN, the radiologists described nodule
characteristics in a predesigned form: a) size, expressed in
millimetres and categorised as±8 mm in diameter, ac-
cording to Fleischner criteria [17]; b) nodule shape,
expressed according to the glossary previously men-
tioned, which considers the border as smooth or irregu-
lar (lobular or specular); c) location, upper, middle or
lower lobule; and d) for those patients who underwent a
CT, nodule appearance (solid, partially solid, ground glass, or
calcified). This form was completed by the radiologists simul-
taneously with the radiology report, in order to standardise the
information.
Given the large sample of the study, we only reviewed
the medical records of patients in whom an SPN was
identified. The following information was collected:
smoking habit (non-smokers, current, or former smokers),
and previous neoplasm. Availability of information on these
patients’ variables (smoking habit or previous neoplasm) did
not appear to be associated with the patient’s other charac-
teristics (such as age, sex, diagnostic test, reason for test, or
nodule characteristics).
For the evaluation of inter-observer agreement, the first
300 tests included in the study were evaluated independent-
ly by the eight radiologists. For the intra-observer agree-
ment, the radiologists re-evaluated 200 studies at least
6 months after the first report. In each study of observer
agreement (excluding the first observation) uncertainties
arising from the reports and their reasons were discussed
in detail. At the end of the study on observer agreement the
discrepancies and their causes were evaluated. In case of
discordance, the consensus was established by the heads of
the two radiology departments, the two radiologists with the
most experience (I.G.A. and J.V.).
Statistical analysis
All data were computerised anonymously and sorted. Statis-
tical precision was determined through the calculation of 95%
confidence intervals using the appropriate method according
to the type of measurement and the available data. All analy-
ses were carried out with the statistical programme Stata
(version 8).
We estimated the prevalence of nodules in the whole
population and the prevalence according to relevant vari-
ables and their 95 % CI. The effect of diverse explicative
variables was considered by means of a stratified analysis
and unconditional logistic regression was used (95 % con-
fidence intervals).
To compare the SPN appearance with selected patient’s
characteristics, a chi squared test or Fisher’s exact test was
used. The variable border was regrouped into two catego-
ries according to the probability of malignancy described
in previous studies [7]: smooth border or irregular border
(including irregular, spiculation, and lobulation). Since
there were no differences between those patients with
SPN characteristics collected and those without them, the
comparison only included those patients with the variables
collected.
Inter- and intra-observer agreement was calculated with the
kappa index, weighting with quadratic weights for ordinal
categories.
Results
Inter-observer and intra-observer agreement
1) Kappa index for the detection of a SPN: a) Intra-observer
agreement: kappa index ranged from 0.785 to 0.893; b)
Inter-observer agreement: kappa index ranged from 0.793
to 0.801 (among eight radiologists);
2) Kappa index for the description of the SPN characteristics:
a) Intra-observer agreement: nodule size (kappa=0.551 –
0.526); nodule location (kappa=0.565 – 0.759); nodule edge
(kappa=0.654 – 0.717); nodule appearance (kappa=0.333 –
0.793); and b) Inter-observer agreement: nodule size
(kappa=0.548 – 0.706); nodule location (kappa=0.822 –
0.928); nodule edge (kappa=0.278 – 0.588); nodule appear-
ance (kappa=0.596 – 1.000).
Characteristics of patients included in the study (Table 1)
During the 2-year enrolment period, 25,529 patients with a
chest image test were included in the study: 12,653 men
(49.6 %) and 12,876 women (50.4 %), and the median age
was 66 years (IQR 53–77; range: 35–104 years). The majority
of the patients were referred from the accident and emergency
department (4,830, 18.9 %), surgery (3,201, 12.5 %), and
pulmonology (3,051, 11.9 %). Most of the patients had chest
radiograph (23,102; 90.5 %) and were out-patients (21,613;
84.7 %). The overall prevalence of SPN in the study was
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Eur Radiol (2014) 24:2174–2182 2177
3.5 % (95 % CI 3.3 – 3.7); the prevalence was 2.1 % (95 % CI
1.9 – 2.3) for chest radiograph and 17.0 % (95 % CI 15.5 –
18.5) for CT.
Prevalence of SPN according to selected variables:
univariable (Table 1) and multivariable analysis for both chest
radiograph and CT
Chest radiograph
The prevalence was 3.3 % in San Juan Hospital and 1.3 % in
Dr. Peset Hospital (p<0.001). This prevalence varied according
to relevant variables. Men showed a higher prevalence than
women (2.6 %, 95%CI 2.3 – 3.9 and 1.6%, 95%CI 1.4 – 1.9,
respectively, p<0.001). Subjects aged 60 – 69 years showed the
highest prevalence (2.6 %, 95 % CI 2.2 – 3.1), while this
prevalence decreased in the other age groups (p=0.001). The
oncology department showed the greatest prevalence of SPN
(3.8 %, 95 % CI 2.6 – 5.4) in comparison with the accident and
emergency department, which showed the lowest rate (0.7 %,
95 % CI 0.5 – 1.0). The disorders under evaluation represented
a broad range of illnesses, and the prevalence of SPN was
highest in disorders categorized as extrapulmonary neoplasm
(4.3%, 95%CI 3.1 – 5.7) and preoperative (3.2%, 95%CI 2.7
– 3.7) (p<0.001). The prevalence of SPN was higher in out-
patients than in in-patients (2.2 %, 95 % CI 2.0 – 2.4 vs. 1.5 %,
95 % CI 1.1 – 2.0, p=0.018).
In multivariable analysis (data not shown) adjusted by all
the significant variables shown in univariable analysis, SPN
were less likely to be detected in women compared to men
(adjusted odds ratio 0.65; 95 % CI 0.54 – 0.79, p<0.001).
Patients older than 50 years were more likely to show
an SPN when compared to patients younger than
50 years. Thus, adjusted OR for patients between 50 –
59 years were OR=1.46; 95 % CI 1.06 – 1.99 p=0.016;
for those between 60 – 69 years: OR=1.75; 95 % CI
1.31 – 2.34, p<0.001, and for those ≥70 years old:
OR=1.63; 95 % CI 1.23 – 2.15, p=0.001). Patients
with a pre-operative request and those with a diagnosis of
extrapulmonary neoplasm were more likely to show an SPN
than those with an unspecified diagnosis (adjusted odds ratio
2.02; 95 % CI 1.54 – 2.66 and adjusted odds ratio 2.37; 95 %
CI 1.61 – 3.51, respectively).
CT
The prevalence in San Juan Hospital was 26.5 % and 12.2 %
in Dr. Peset Hospital. This prevalence varied according to
relevant variables. Subjects aged 60 – 69 showed the highest
prevalence (21.2 %, 95 % CI 18.0 – 24.7), while this preva-
lence decreased in the other age groups (p=0.005). The urol-
ogy and anaesthesia departments showed the greatest preva-
lence of SPN (36.1 %, 95 % CI 20.8 – 53.8 and 35.0 %, 95 %
CI 15.4 – 59.2, respectively) in comparison with the accident
and emergency department, which showed the lowest rate
(11.3 %, 95 % CI 6.8 – 17.2). The disorders under evaluation
represented a broad range of illnesses, and the prevalence of
SPN was highest in disorders categorized as preoperative
(53.8 %, 95 % CI 25.1 – 80.8) (p<0.001). In multivariable
analysis (data not shown) adjusted by all the significant var-
iables shown in univariable analysis, patients 60 – 69 years of
age were more likely to show an SPN than patients younger
than 50 years (adjusted odds ratio 1.78; 95 % CI 1.23 – 2.57,
p=0.002). Patients with a preoperative diagnosis and those
with a diagnosis of extrapulmonary neoplasm were more
likely to show an SPN than those with an unspecified diag-
nosis (adjusted odds ratio 7.61; 95 % CI 2.41 – 24.04 and
adjusted odds ratio 1.60; 95 % CI 1.05 – 2.43, respectively).
Characteristics of the SPN and description of relevant
variables of those patients with a SPN for both chest
radiograph and CT (Table 2)
Chest radiograph
Median diameter of the SPNwas 10mm (P25-P75: 7 – 14mm).
More than half of the nodules were larger than 8 mm (59.7 %,
95 % CI 55.1 – 64.1). SPN was more frequently located in the
upper lobe (54.5 %, 95 % CI 50.0 – 60.0). An irregular or not
well defined border was found in 144 nodules (29.9 %,
95 % CI 25.9 – 34.2) and the spiculated border was
described in 62 nodules. A high percentage of patients
with an SPN did not have a previous malignancy
(65.9 %, 95 % CI 61.5 – 70.1) and were former or current
smokers (59.0 %, 95 % CI 54.5 – 63.5).
CT
Median diameter of the SPN was 8 mm (P25-P75: 5 – 13 mm).
Half of the nodules were smaller than 8 mm (51.3 %, 95 % CI
46.4 – 56.2). SPN was more frequently located in the upper
lobe (48.1 %, 95 % CI 43.1 – 53.0). An irregular or not
well-defined border was found in 151 nodules (36.6 %, 95 %
CI 32.0 – 41.5) and the spiculated border was described in 44
nodules. More than half of the nodules had a solid appearance
(225; 54.6 %, 95 % CI 49.8 – 59.4), the frequency of ground-
glass opacity was 6.1 %, (95 % CI 4.0 – 8.8), and the
percentage of partly solid nodules was 3.4 % (95 % CI 1.9 –
5.6). Nearly 70 % of patients with an SPN did not have a
previous malignancy (69.9 %, 95 % CI 65.2 – 74.3), and
60.4 %, (95 % CI 55.5 – 65.2) were former or current
smokers.
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Characteristics of SPN according to selected variables
We also tested the difference in SPN size (diameter), border
(regular or irregular), and location (upper, middle, or lower)
according to selected patient’s characteristics for both chest
radiograph and CT. We only included patients with nodule
characteristics available (data not shown). We describe the
significant associations:
Chest radiograph
– Border: Smokers were more likely to show nodules with
irregular border than non-smokers (96/166; 57.8 % vs.
23/55; 41.8 %; p=0.039)
CT
– Size:
– Patients older than 70 years (77/145; 53.1 %) and those
aged 60 – 69 years (60/121; 49.6 %) were more likely to
show a nodule larger than 8 mm than patients aged 50 –
59 years (33/83; 39.8 %) and those younger than 50 years
(15/49; 30.6 %) (p=0.023).
– Men were more likely to show a nodule larger than 8 mm
than women (126/250; 50.4 % vs. 59/148; 39.9 %; p=
0.042)
– Patients with a respiratory diagnosis (67/137; 48.9 %)
were more likely to show a nodule larger than 8 mm than
patients with other diagnoses such as extrapulmonary
neoplasm (17/55; 30.9 %) (p=0.046).
Table 2 Characteristics of the
893 SPN detected in the imaging
tests carried out in the study, and
the description of relevant vari-
ables of patients with an SPN for
both chest radiograph and CT
CHARACTERISTICS CHEST RADIOGRAPH CT
N % 95 % CI N % 95 % CI
NODULE
Diameter (mm)
< 8 168 34.9 (30.7-39.4) 212 51.3 (46.4-56.2)
> 8 287 59.7 (55.1-64.1) 188 45.5 (40.6-50.5)
Not specified 25 5.2 (3.4-7.6) 13 3.1 (1.7-5.3)
Localization
Upper lobe 262 54.5 (50.0-60.0) 198 48.1 (43.1-53.0)
Lower lobe 39 8.1 (5.8-10.9) 50 12.1 (9.1-15.7)
Middle lobe 160 33.3 (29.1-37.7) 150 36.4 (31.8-41.3)
Not specified 20 4.2 (2.6-6.3) 14 3.4 (1.9-5.6)
Border
Smooth border or well defined border 128 26.6 (22.7-30.8) 88 21.4 (17.5-25.6)
Irregular or not well defined 144 29.9 (25.9-34.2) 151 36.6 (32.0-41.5)
- Spiculation 62 43.1 (34.8-51.6) 44 29.1 (22.0-37.1)
- Lobulation 33 22.9 (16.3-30.7) 41 27.2 (20.2-35.0)
- Other 49 34.0 (26.3-42.4) 66 43.7 (35.7-52.0)
Not specified 209 43.5 (39.0-48.0) 173 42.0 (37.2-46.9)
Opacity on CT
Solid 225 54.6 (49.7-59.5)
Ground glass 25 6.1 (4.0-8.8)
Calcification 16 3.9 (2.2-6.2)
Partly solid 14 3.4 (1.9-5.6)
Not specified 132 32.0 (27.6-36.8)
PATIENT
Previous malignancy
No 317 65.9 (61.5-70.1) 288 69.9 (65.2-74.3)
Yes 164 34.1 (29.9-38.5) 124 30.1 (25.7-34.8)
Smoking habit
No 100 20.8 (17.2-24.7) 86 20.9 (17.0-25.1)
Former and current 284 59.0 (54.5-63.5) 249 60.4 (55.5-65.2)
Not specified 97 20.2 (16.7-24.0) 77 18.7 (15.0-22.8)
Total 481 100.0 412 100.0
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– Border: Men were more likely to show a nodule with
irregular border than women (106/156; 67.9 % vs. 45/83;
54.2 %; p=0.036)
Discussion
The study shows an important prevalence of newly diagnosed
SPN 2.1 % (95 % CI 1.9 – 2.3) for chest radiograph and
17.0% (95%CI 15.5 – 18.5) for CT in the imaging tests of the
25,529 patients included in the study. For both types of
imaging tests, this prevalence varied according to age, reason
for test, and clinical department. Moreover, in patients under-
going a chest radiograph, the prevalence varied according to
sex and setting. Patients older than 50 years or those who were
undergoing chest imaging in the course of a preoperative
examination for extrapulmonary neoplasm were more likely
to show an SPN. Men and outpatients having a chest radio-
graph were also more likely to show an SPN. In relation to
SPN characteristics, nodules detected by radiograph were larg-
er than 8mm, as opposed to nodules detected by CT. However,
for both types of tests, detected nodules were mainly located in
the upper lobes and with irregular borders. In those patients
who had an SPN detected by chest radiograph, irregular border
was associated with smoking (current and former). In patients
who had a CT, a size exceeding 8 mm was associated with
smoking. SPNs appeared to be associated with age≥60 years,
diagnosis of a respiratory illness, or male gender. In addition,
an irregular border was also associated with sex (men).
Recent screening studies in high-risk populations using
low-dose CT reported a higher SPN prevalence than in our
study (73.7 % in the PanCan Study [9] and 27.9 % in the
National Lung Screening Trial [8], vs. 17.0 % in our study).
However, according to previous screening studies using CT,
the prevalence of SPNs ranged from 8 to 51 % [3]. The SPN
prevalence in the screening studies using radiograph was also
higher than that of our study (6.2 % in the National Lung
Screening Trial [8] vs. 2.1 % in our study). Previous hospital-
based studies using chest radiograph to detect SPN also
showed a higher prevalence (23 to 75 %); however, as we
previously mentioned, the lack of description of patients’
features or the highly selected population could have affected
the results of these studies [6, 13]. The lower SPN prevalence
shown in our study could be explained by the unselected
nature of our clinical population by including patients having
chest imaging from all clinical departments including the
accident and emergency department.
For both, patients having a chest radiograph and those
having a CT, the prevalence of SPNs was higher in those
patients with a diagnosis of neoplasm (4.3 % for chest radio-
graph and 18.8 % for CT) or those undergoing a preoperative
examination (3.2 % for chest radiograph and 53.8 % for CT)
compared to patients with other diagnoses. According to a
previous study [19], 75 % of patients with extrapulmonary
carcinoma or sarcoma who had a CT showed a SPN, whereas
our study showed a lower percentage, probably due to the
inclusion of an unselected population in our study.
Most of the detected SPNs had characteristics that have
been associated with malignancy according to previous quan-
titative models [7]. A systematic literature review carried out
in 2007 by the ACCP [3] described that irregular, spiculated,
and lobulated nodule borders were more predictive of malig-
nancy than smooth edges. Nodule size (SPN bigger than
8 mm, according to Fleischner recommendations [17],) and
nodule location (those SPN located in upper lobe are more
likely to be malignant [20]) are also related with malignancy.
In our study, for patients who had both a chest radiograph and
a CT, and taking into account only those patients with a nodule
characterization, less than half of them showed smooth edges.
Of the SPN detected by chest radiology, 59.7 % were larger
than 8 mm. This percentage is lower than the data shown in
the National Lung Screening Study, where more than 70 % of
the SPN detected by chest radiograph were larger than 8 mm.
Regarding SPN observed by CT, 44.9 % were larger than
8 mm, which is similar to the 43 % found in the National
Lung Screening Study. Thus, according to nodule size, the
pretest probability of malignancy could be lower in our study
than in screening studies.
Both ground-glass and partially solid nodules are consid-
ered subsolid nodules in contrast with solid nodules [17].
Regarding the malignancy of nodules according to the dif-
ferent types of opacity, different opinions exist in the liter-
ature; previously some studies [21] found ground-glass
opacities to be associated with malignancy, but other studies
did not include these characteristics in their prediction
models [9]. However, when partially solid and ground-
glass nodules were pooled [22], the prevalence of malig-
nancy was higher than for solid nodules. In any case,
according to Fleischner recommendations [17], these types
of nodules should be managed conservatively. In our study,
the percentage of ground-glass nodules was 6.1 % and
3.4 % for partially solid nodules. Although the frequency
of ground-glass nodules is lower than those shown, for
example, in the Pan Can Study [9] (15.8 %), the frequency
of subsolid nodules is higher than those shown in other
screening studies, such as the Nelson study [23]. Thus, the
likelihood of malignancy in our population could be high.
Although the prevalence of SPN observed in our study in
much lower than in screening studies, the proportion of cases
with irregular nodules (both for patients with a chest radio-
graph and those with a CT), is similar to that observed in
screening studies [3]. In our study, taking into account only
those patients with a nodule characterization, 36.8 % of the
patients with a CT showed smooth nodules, in comparison
with previous studies using CT, where the prevalence of
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smooth nodules varied from 20 to 44 %. However, we were
unable to obtain data related to SPN morphology in some
cases, making it difficult to compare the results.
Some patient characteristics such as sex, advanced age, or
history of smoking have been associated with a higher risk of
malignant SPN [24]. In our study, men, advanced age, respi-
ratory disease, and current or former smoking were associated
with SPN characteristics related to malignancy, such as nodule
diameter or irregular border. In our study, in patients who had
a chest radiograph, smokers were more likely to show nodules
with irregular edges than non-smokers. Swensen [4] reported
an increased likelihood of malignancy with the higher number
of cigarettes per day. Although we did not quantify the
smoking habit, it seems to be associated with SPN character-
istics related with malignancy, as would be expected. In
patients having a CT, men were more likely to show nodules
bigger than 8 mm and nodules with irregular edges than
women. Moreover, patients ≥60 years old were more likely
to show nodules bigger than 8 mm. According to previous
studies [7, 25], the patient’s age is one of the most important
clinical factors associated with malignancy. In fact, Swensen
[4] described a 2.1 likelihood ratio of malignancy in patients
60 to 69 years of age, and a 5.7 in patients 70 to 83 years of
age. In multivariable analysis, the patient’s previous malig-
nancy was not associated with any SPN variables related with
malignancy. In previous studies, the relationship between lung
cancer and previous malignancy is not clear [6]. However,
some morphologic variables such as spiculation or irregular
borders may dilute the association in multivariable analysis
given that metastases are usually well defined and have no
spiculation.
This study presents new data about SPN detected in a
clinic-based population for both chest radiograph and CT,
but some limitations should be addressed. The observer var-
iability in the determination of the presence of nodules and
their characteristics was less than perfect and should be ac-
knowledged as one limitation of the study. This limitation in
imaging studies has been shown in other studies [26]. All the
radiologists who participated in the study followed the same
criteria for the detection and characterization of nodules.
Moreover, the evaluation of observer agreement, its causes
and the determination of a consensus with the participation of
two experts helped to limit the impact of this problem in the
overall study findings.
The lack of electronic medical records meant that we were
unable to retrieve complete information for a relatively high
proportion of cases. Incomplete information on some patients’
data, such as smoking habit, occupational exposure, or family
history, could lead to information bias. However, there were
no significant differences with respect to other patient’s char-
acteristics (such as age, sex, diagnostic test, reason for test, or
nodule characteristics) between patients with the available
data and those without.
Despite the similar populations, and the use by radiologists
of similar protocols to detect SPN, we observed a different
SPN prevalence between the two hospitals included in the
study. The reason for this difference could be due to several
factors; in addition to the usual inter-reader variation observed
when ordering a diagnostic test [27], there were some differ-
ences related to the type of clinical departments included in
each hospital. Only the hospital that showed the lowest prev-
alence of SPN included the 4,830 imaging tests carried out in
the emergency department (the prevalence of SPN in this
department is 1.1 %). Moreover, 86 % of the imaging tests
ordered from primary care were included in the hospital that
showed the highest prevalence (the prevalence of SPN in the
primary care department was 4.6 %).
As opposed to previous studies [28], we did not exclude
patients with a malignancy outside the chest because we
wanted to show the whole spectrum of patients with an SPN
in a clinic-based population. This study differs in many ways
from previous evaluations of SPNs. Our study is based on
information from consecutive radiology reports, representa-
tive of the general clinic-based population in two health dis-
tricts and it is not biased by patient selection. It should be
underlined that in order to establish the predictive value of
these, SPN and patient characteristics for lung cancer will be
ascertained once follow-up of the cohort, now under investi-
gation, will be accomplished.
In conclusion, we have shown that SPNs may be observed
in one of every six patients undergoing CTand in one of every
47 patients undergoing a chest radiograph in a routine clinical
setting. This was lower than that shown in screening studies
using a highly selected population. Some significant differ-
ences related to SPN characteristics have also been shown
between our population and those included in screening stud-
ies, such as nodule size (smaller in our study than in screening
studies). Moreover, some patient characteristics such as age,
sex, respiratory disease, or smoking habit were associated
with nodule characteristics that are known to be associated
to malignancy (bigger nodule size or irregular border).
Given the difference in nodule characteristics and variables
associated with the nodule prevalence for patients who have
had a CT or a chest radiograph, it is important to study these
techniques separately in the general population. Once long-
term risk of cancer is determined, these results will be appli-
cable to estimate the clinical ‘pretest’ probability of malignan-
cy of a SPN detected in a clinic-based population for both
chest radiograph and CT.
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